scholarly journals 894. Treating Neurological Disorders of MPS IIIB by AAV-CNS Gene Delivery Targeting Reactive Oxygen Species

2009 ◽  
Vol 17 ◽  
pp. S341-S342
2016 ◽  
Vol 28 (9) ◽  
pp. 1714-1714 ◽  
Author(s):  
Xin Liu ◽  
Jiajia Xiang ◽  
Dingcheng Zhu ◽  
Liming Jiang ◽  
Zhuxian Zhou ◽  
...  

2021 ◽  
Vol 19 ◽  
Author(s):  
Waseem Hassan ◽  
Hamsa Noreen ◽  
Shakila Rehman ◽  
Mohammad Amjad Kamal ◽  
Joao Batista Teixeira da Rocha

Background: Oxidative stress is one of the main contributing factors involved in cerebral biochemical impairment. The higher susceptibility of the central nervous system to reactive oxygen species mediated damage could be attributed to several factors. For example, neurons use a greater quantity of oxygen, many parts of the brain have higher concentraton of iron, and neuronal mitochondria produce huge content of hydrogen peroxide. In addition, neuronal membranes have polyunsaturated fatty acids, which are predominantly vulnerable to oxidative stress (OS). OS is the imbalance between reactive oxygen species generation and cellular antioxidant potential. This may lead to various pathological conditions and diseases, especially neurodegenerative diseases such as, Parkinson’s, Alzheimer’s, and Huntington’s diseases. Objectives: In this study, we explored the involvement of OS in neurodegenerative diseases. Methods: We used different search terms like “oxidative stress and neurological disorders” “free radicals and neurodegenerative disorders” “oxidative stress, free radicals, and neurological disorders” and “association of oxidative stress with the name of disorders taken from the list of neurological disorders. We tried to summarize the source, biological effects, and physiologic functions of ROS. Results: Finally, it was noted that more than 190 neurological disorders are associated with oxidative stress.


2017 ◽  
Vol 5 (6) ◽  
pp. 1174-1182 ◽  
Author(s):  
Qiurong Deng ◽  
Xudong Li ◽  
Lipeng Zhu ◽  
Hua He ◽  
Donglai Chen ◽  
...  

Fluorinated, diselenide-crosslinked polyplexes were developed to enable ROS-responsive and serum-resistant gene delivery in cancer cells.


2019 ◽  
Vol 20 (5) ◽  
pp. 1899-1913 ◽  
Author(s):  
Yuxin Zhang ◽  
Jie Zhou ◽  
Shengnan Ma ◽  
Yiyan He ◽  
Jun Yang ◽  
...  

2015 ◽  
Vol 28 (9) ◽  
pp. 1743-1752 ◽  
Author(s):  
Xin Liu ◽  
Jiajia Xiang ◽  
Dingcheng Zhu ◽  
Liming Jiang ◽  
Zhuxian Zhou ◽  
...  

Antioxidants ◽  
2021 ◽  
Vol 10 (5) ◽  
pp. 739
Author(s):  
Song-Hee Lee ◽  
Min-Woo Lee ◽  
Dong-Gyun Ko ◽  
Bo-Young Choi ◽  
Sang-Won Suh

Oxidative stress is a well-known common pathological process involved in mediating acute neurological injuries, such as stroke, traumatic brain injury, epilepsy, and hypoglycemia-related neuronal injury. However, effective therapeutic measures aimed at scavenging free reactive oxygen species have shown little success in clinical trials. Recent studies have revealed that NADPH oxidase, a membrane-bound enzyme complex that catalyzes the production of a superoxide free radical, is one of the major sources of cellular reactive oxygen species in acute neurological disorders. Furthermore, several studies, including our previous ones, have shown that the inhibition of NADPH oxidase can reduce subsequent neuronal injury in neurological disease. Moreover, maintaining appropriate levels of NADPH oxidase has also been shown to be associated with proper neurogenesis after neuronal injury. This review aims to present a comprehensive overview of the role of NADPH oxidase in neuronal death and neurogenesis in multiple acute neurological disorders and to explore potential pharmacological strategies targeting the NADPH-related oxidative stress pathways.


Sign in / Sign up

Export Citation Format

Share Document